Quote | Biomind Labs (OTCMKTS:BMNDF)
Last: | $0.372 |
---|---|
Change Percent: | 0.0% |
Open: | $0.372 |
Close: | $0.372 |
High: | $0.372 |
Low: | $0.372 |
Volume: | 400 |
Last Trade Date Time: | 07/18/2024 03:00:00 am |
News | Biomind Labs (OTCMKTS:BMNDF)
TORONTO, ON / ACCESSWIRE / July 18, 2024 / Biomind Labs Inc. (" Biomind " or the " Company ") (CBOE:BMND) (OTC PINK:BMNDF) (FRA:3XI) , a leading biotech company dedicated to developing the next-generation of pharmaceuticals targeting the root causes of neurological disorders, announced the ...
Biomind Labs Inc. (“ Biomind ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeti...
Message Board Posts | Biomind Labs (OTCMKTS:BMNDF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
TORONTO, ON / ACCESSWIRE / July 18, 2024 / Biomind Labs Inc. (" Biomind " or the " Company ") (CBOE:BMND) (OTC PINK:BMNDF) (FRA:3XI) , a leading biotech company dedicated to developing the next-generation of pharmaceuticals targeting the root causes of neurological disorders, announced the ...
Biomind Labs Inc. (“ Biomind ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeti...
Biomind Labs Inc. (“ Biomind Labs ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by ta...